Granules India Limited
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally. It offers paracetamol, metformin, guaifenesin, and methocarbamol, as well as prescription and over-the-counter products. The company also develops and manufactures tablets, capsules, press fits, oral solutions, s… Read more
Granules India Limited (GRANULES) - Total Assets
Latest total assets as of September 2025: ₹69.44 Billion INR
Based on the latest financial reports, Granules India Limited (GRANULES) holds total assets worth ₹69.44 Billion INR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Granules India Limited - Total Assets Trend (2006–2025)
This chart illustrates how Granules India Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Granules India Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Granules India Limited's total assets of ₹69.44 Billion consist of 49.8% current assets and 50.2% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹2.46 Billion | 9.5% |
| Accounts Receivable | ₹9.55 Billion | 15.3% |
| Inventory | ₹13.43 Billion | 21.5% |
| Property, Plant & Equipment | ₹26.54 Billion | 42.5% |
| Intangible Assets | ₹2.12 Billion | 3.4% |
| Goodwill | ₹0.00 | 0.0% |
Asset Composition Trend (2006–2025)
This chart illustrates how Granules India Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Granules India Limited's current assets represent 49.8% of total assets in 2025, an increase from 33.9% in 2006.
- Cash Position: Cash and equivalents constituted 9.5% of total assets in 2025, up from 0.9% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 13.0% in 2006.
- Asset Diversification: The largest asset category is property, plant & equipment at 42.5% of total assets.
Granules India Limited Competitors by Total Assets
Key competitors of Granules India Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Granules India Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Granules India Limited generates 0.72x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Granules India Limited generates $8.02 in net profit.
Granules India Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.28 | 1.54 | 1.63 |
| Quick Ratio | 0.66 | 0.72 | 1.09 |
| Cash Ratio | 0.26 | 0.13 | 0.00 |
| Working Capital | ₹6.70 Billion | ₹ 9.14 Billion | ₹ 7.18 Billion |
Granules India Limited - Advanced Valuation Insights
This section examines the relationship between Granules India Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.43 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | 13.3% |
| Total Assets | ₹62.53 Billion |
| Market Capitalization | $940.74 Million USD |
Valuation Analysis
Below Book Valuation: The market values Granules India Limited's assets below their book value (0.02 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Granules India Limited's assets grew by 13.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Granules India Limited (2006–2025)
The table below shows the annual total assets of Granules India Limited from 2006 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | ₹62.53 Billion | +13.25% |
| 2024-03-31 | ₹55.21 Billion | +12.57% |
| 2023-03-31 | ₹49.05 Billion | +8.68% |
| 2022-03-31 | ₹45.13 Billion | +21.53% |
| 2021-03-31 | ₹37.13 Billion | +12.48% |
| 2020-03-31 | ₹33.01 Billion | +10.68% |
| 2019-03-31 | ₹29.83 Billion | +12.82% |
| 2018-03-31 | ₹26.44 Billion | +40.90% |
| 2017-03-31 | ₹18.76 Billion | +29.15% |
| 2016-03-31 | ₹14.53 Billion | +21.36% |
| 2015-03-31 | ₹11.97 Billion | +20.68% |
| 2014-03-31 | ₹9.92 Billion | +45.30% |
| 2013-03-31 | ₹6.83 Billion | +19.50% |
| 2012-03-31 | ₹5.71 Billion | +31.38% |
| 2011-03-31 | ₹4.35 Billion | +5.56% |
| 2010-03-31 | ₹4.12 Billion | +1.78% |
| 2009-03-31 | ₹4.05 Billion | +8.80% |
| 2008-03-31 | ₹3.72 Billion | +12.66% |
| 2007-03-31 | ₹3.30 Billion | +49.47% |
| 2006-03-31 | ₹2.21 Billion | -- |